Merlin@Home Software Model EX2000 v8.2.2 for Merlin@Home Transmitter Models EX1150, EX1150W, EX11...
FDA Device Recall #Z-0033-2018 — Class II — August 28, 2017
Recall Summary
| Recall Number | Z-0033-2018 |
| Classification | Class II — Moderate risk |
| Date Initiated | August 28, 2017 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | St Jude Medical Inc. |
| Location | Sylmar, CA |
| Product Type | Devices |
| Quantity | 495,011 units (391,093 in US) |
Product Description
Merlin@Home Software Model EX2000 v8.2.2 for Merlin@Home Transmitter Models EX1150, EX1150W, EX1100, and EX1100W. The Merlin@home Transmitters are a component of St. Jude Medicals (SJM) Remote Care System. These Merlin@home transmitters are used to retrieve information from the SJM implantable medical device (IMD) using RF telemetry. The data is then sent back to the Merlin.net Patient Care Network through a built-in modem or, alternatively, through a USB cellular adapter or a USB based Broadband Kit. The transmitted data enables clinicians to remotely monitor a patients IMD using a secure, encrypted, password-protected web site, thus reducing the number of in-clinic visits a patient needs to make to their physician. The transmitter monitors the patients device daily between scheduled follow-ups and can alert a clinician if it detects anything out of the norm.
Reason for Recall
New pacemaker firmware was developed to further mitigate the risk of unauthorized access to our pacemakers that utilize radio frequency (RF) communications.
Distribution Pattern
Worldwide Distribution
Lot / Code Information
Model EX1100 - GTIN 05414734504782 and Model EX1150 - GTIN 05414734404334
Other Recalls from St Jude Medical Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2075-2019 | Class I | ELLIPSE DR, Tiered-therapy cardioverter/defibri... | Jun 20, 2019 |
| Z-2070-2019 | Class I | ELLIPSE VR, REF: CD1377-36C Implantable card... | Jun 20, 2019 |
| Z-2071-2019 | Class I | ELLIPSE VR, REF: CD1377-36QC Implantable car... | Jun 20, 2019 |
| Z-2072-2019 | Class I | ELLIPSE VR, Tiered-therapy cardioverter/defibri... | Jun 20, 2019 |
| Z-2073-2019 | Class I | ELLIPSE DR, REF: CD2377-36QC Implantable car... | Jun 20, 2019 |
Frequently Asked Questions
A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.